About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Chrm2tm1Jwe
targeted mutation 1, Jurgen Wess
MGI:2155543
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Chrm2tm1Jwe/Chrm2tm1Jwe B6.129S4-Chrm2tm1Jwe MGI:4429952
hm2
Chrm2tm1Jwe/Chrm2tm1Jwe involves: 129S4/SvJae * CF-1 MGI:2662619
ht3
Chrm2tm1Jwe/Chrm2+ involves: 129S4/SvJae * CF-1 MGI:3665220
cx4
Chrm2tm1Jwe/Chrm2tm1Jwe
Chrm3tm1Jwe/Chrm3tm1Jwe
involves: 129S4/SvJae * 129S6/SvEvTac * CF-1 MGI:4829438
cx5
Chrm2tm1Jwe/Chrm2tm1Jwe
Chrm4tm1Jwe/Chrm4tm1Jwe
involves: 129S4/SvJae * 129S6/SvEvTac * CF-1 MGI:4829449


Genotype
MGI:4429952
hm1
Allelic
Composition
Chrm2tm1Jwe/Chrm2tm1Jwe
Genetic
Background
B6.129S4-Chrm2tm1Jwe
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chrm2tm1Jwe mutation (1 available); any Chrm2 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
behavior/neurological
• male mice exhibit a loss of female chasing, sniffing, and mounting behaviors compared with wild-type mice
• 6 of 8 mice do not emit ultrasonic vocalizations unlike wild-type mice
• mice exhibit decreased peak frequency of ultrasonic vocalization compared with wild-type mice
• however, duration and bandwidths of ultrasonic vocalizations are normal




Genotype
MGI:2662619
hm2
Allelic
Composition
Chrm2tm1Jwe/Chrm2tm1Jwe
Genetic
Background
involves: 129S4/SvJae * CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chrm2tm1Jwe mutation (1 available); any Chrm2 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• homozygotes exhibit severely impaired hypothermic response to the centrally acting, nonselective muscarinic agonist oxotremorine
• in contrast, oxotremorine-induced hypersalivation responses remain largely unaffected relative to wild-type littermates
• compared with bronchi from control animals, mutant bronchi showed similar rapid bronchoconstriction responses but a subsequent relaxation in the presence of 10-4M muscarine
• the sustained bronchoconstriction of smaller airways after a single application of 10-4M muscarine was greatly reduced in mutant mice
• the initial rapid bronchoconstriction response did no differ between mutant and control mice

behavior/neurological
• homozygotes exhibit absence of tremorogenic and severely impaired analgesic responses to the centrally acting, nonselective muscarinic agonist oxotremorine
• homozygotes display severely reduced oxotremorine-dependent antinociceptive responses on both the tail-flick and hot plate test relative to wild-type mice
• however, homozygotes show no significant differences in their responsiveness to the opioid analgesic morphine

growth/size/body
• homozygotes are viable and healthy with no morphological or locomotor abnormalities; however, adults weigh ~5% (1.5-2.5 g) less than wild-type littermates

cardiovascular system
N
• adult male homozygotes show no significant differences in acetylcholine- or sodium nitroprusside-induced dose-dependent dilation of pre-constricted coronary arteries relative to wild-type males
• similarly, male homozygotes show no significant changes in acetylcholine-, calcium ionophore A23187- or papavarine-induced relaxation of aortic rings relative to wild-type males
• spontaneously beating atria derived from mutant mice show a normal basal atrial rate relative to wild-type atria
• strikingly, mutant atrial preparations are unresponsive to the bradycardic effects of muscarinic agonist carbamylcholine, even at the highest carbamylcholine concentration (10-4 M)
• in contrast, adenosine, a noncholinergic agonist, produces a similar concentration-dependent bradycardia in atria from wild-type and mutant mice

muscle
• homozygotes display impaired carbamylcholine-dependent smooth muscle contractile responses in stomach fundus, urinary bladder, and tracheal smooth muscle preparations, with carbamylcholine potency reduced by a factor of ~2 (J:60451)
• in addition, the affinity of the M2 "selective" receptor antagonist AF-DX116 in inhibiting carbamylcholine-induced smooth muscle contraction is significantly reduced (J:60451)
• a modest inhibition of the maximum contractile response to carbamylcholine is seen in homozygous mutant gallbladders compared with wild-type mice (J:125455)

liver/biliary system
• a modest inhibition of the maximum contractile response to carbamylcholine is seen in homozygous mutant gallbladders compared with wild-type mice

respiratory system
• compared with bronchi from control animals, mutant bronchi showed similar rapid bronchoconstriction responses but a subsequent relaxation in the presence of 10-4M muscarine
• the sustained bronchoconstriction of smaller airways after a single application of 10-4M muscarine was greatly reduced in mutant mice
• the initial rapid bronchoconstriction response did no differ between mutant and control mice

nervous system
• facilitation of cortical synaptic transmission induced by 200 micromolar acetylcholine, measured the changes in amplitude of extracellular field potentials (FPs) evoked by stimulation of white matter (WM) and recording in cortical layer II/III, is absent or significantly reduced
• depression of cortical synaptic transmission induced by 1.5mm acetylcholine is not affected




Genotype
MGI:3665220
ht3
Allelic
Composition
Chrm2tm1Jwe/Chrm2+
Genetic
Background
involves: 129S4/SvJae * CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chrm2tm1Jwe mutation (1 available); any Chrm2 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• heterozygotes exhibit reduced hypothermic responses to the centrally acting, nonselective muscarinic agonist oxotremorine

behavior/neurological
• heterozygotes exhibit absence of tremorogenic responses to the centrally acting, nonselective muscarinic agonist oxotremorine




Genotype
MGI:4829438
cx4
Allelic
Composition
Chrm2tm1Jwe/Chrm2tm1Jwe
Chrm3tm1Jwe/Chrm3tm1Jwe
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac * CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chrm2tm1Jwe mutation (1 available); any Chrm2 mutation (32 available)
Chrm3tm1Jwe mutation (1 available); any Chrm3 mutation (50 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
respiratory system
N
• the bronchoconstriction response to the cumulative application of muscarine (10-8M to 10-4M) is completely abolished in double homozygous mutant mice




Genotype
MGI:4829449
cx5
Allelic
Composition
Chrm2tm1Jwe/Chrm2tm1Jwe
Chrm4tm1Jwe/Chrm4tm1Jwe
Genetic
Background
involves: 129S4/SvJae * 129S6/SvEvTac * CF-1
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chrm2tm1Jwe mutation (1 available); any Chrm2 mutation (32 available)
Chrm4tm1Jwe mutation (1 available); any Chrm4 mutation (33 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• fast Fourier transform (FFT) analysis shows that the paradoxical sleep-theta peak frequency (TPF) values in double homozygous mice are spectrally distinct during the dark phase, with a frequency increase in mutants
• the cumulative theta power is significantly decreased during the light phase for paradoxical sleep in mutant vs. control mice
• facilitation of cortical synaptic transmission induced by 200 micromolar acetylcholine, measured the changes in amplitude of extracellular field potentials (FPs) evoked by stimulation of white matter (WM) and recording in cortical layer II/III, is absent or significantly reduced
• depression of cortical synaptic transmission induced by 1.5mm acetylcholine is not affected

behavior/neurological
N
• no differences regarding the sleep vigilance states, including paradoxical sleep, are seen in double homozygous mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory